Pathways for the bradykinin B1 receptor-mediated diabetic hyperalgesia in mice

被引：0
|
作者：
B. H. Gabra
P. Sirois
机构：
[1] University of Sherbrooke,Institute of Pharmacology of Sherbrooke, School of Medicine
来源：
Inflammation Research | 2004年 / 53卷
关键词：
Type 1 diabetes; Hyperalgesia; Kinins; Bradykinin B; receptors; Nitric oxide; Substance P; Calcitonin gene-related peptide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: Experimental evidence has shown that the bradykinin B1 receptor (BKB1-R) is involved in the development of hyperalgesia associated with diabetes since specific BKB1-R antagonists significantly inhibited the hyperalgesic activity observed in streptozotocin (STZ)-mice in thermal nociceptive tests.
引用
收藏
页码：653 / 657
页数：4
相关论文
共 50 条
  • [21] Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice
    Gabra, BH
    Sirois, P
    NEUROPEPTIDES, 2003, 37 (01) : 36 - 44
  • [22] Nociception and inflammatory hyperalgesia in B-2 bradykinin receptor knockout mice
    Boyce, S
    Rupniak, NMJ
    Carlson, EJ
    Webb, JK
    Borkowski, JA
    Hess, JF
    Strader, CD
    Hill, RG
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 : P245 - P245
  • [23] Nociception and inflammatory hyperalgesia in B-2 bradykinin receptor knockout mice
    Boyce, S
    Rupniak, NMJ
    Carlson, EJ
    Webb, J
    Borkowski, JA
    Hess, JF
    Strader, CD
    Hill, RG
    IMMUNOPHARMACOLOGY, 1996, 33 (1-3): : 333 - 335
  • [24] Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice
    Gabra, BH
    Sirois, P
    PEPTIDES, 2003, 24 (08) : 1131 - 1139
  • [25] The Bradykinin B1 Receptor Regulates Aβ Deposition and Neuroinflammation in Tg-SwDI Mice
    Passos, Giselle F.
    Medeiros, Rodrigo
    Cheng, David
    Vasilevko, Vitaly
    LaFerla, Frank M.
    Cribbs, David H.
    AMERICAN JOURNAL OF PATHOLOGY, 2013, 182 (05): : 1740 - 1749
  • [26] Upregulation of kinin B1 receptor-mediated responses by adrenal hormones.
    Cabrini, DA
    Tratsk, KS
    Campos, MM
    Souza, GEP
    Calixto, JB
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R337 - R337
  • [27] Activation of bradykinin B1 receptor by ACE inhibitors
    Ignjatovic, T
    Tan, FL
    Brovkovych, V
    Skidgel, RA
    Erdös, EG
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2002, 2 (13-14) : 1787 - 1793
  • [28] Small molecule antagonists of the bradykinin B1 receptor
    Horlick, RA
    Ohlmeyer, MH
    Stroke, IL
    Strohl, B
    Pan, GH
    Schilling, AE
    Paradkar, V
    Quintero, JG
    You, M
    Riviello, C
    Thorn, MB
    Damaj, B
    Fitzpatrick, VD
    Dolle, RE
    Webb, ML
    Baldwin, JJ
    Sigal, NH
    IMMUNOPHARMACOLOGY, 1999, 43 (2-3): : 169 - 177
  • [29] Targeting the bradykinin B1 receptor to reduce pain
    Chen, Jian Jeffrey
    Johnson, Eileen J.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (01) : 21 - 35
  • [30] Role of ssarrestins in bradykinin B2 receptor-mediated signalling
    Zimmerman, Brandon
    Simaan, May
    Akoume, Marie-Yvonne
    Houri, Nadia
    Chevallier, Stephanie
    Seguela, Philippe
    Laporte, Stephane A.
    CELLULAR SIGNALLING, 2011, 23 (04) : 648 - 659
12345